Skip to main content
BioVentrix obtains $15M in offering

An offering of equity and convertible notes involving 152 unidentified investors has pulled in $14.5 million for BioVentrix, according to a filing with the SEC. The company, which makes the Revivent TC transcatheter ventricular enhancement system, is not looking to raise more funds in the round.

Full Story: